Events in the Series
World RNA Conference Calendar
RNA-based medicines have taken the spotlight in recent years and, following countless investments and collaborations, we have seen tremendous breakthroughs in development of RNA-based and RNA-targeting therapeutics and vaccines.
The World RNA Series presents a comprehensive portfolio of niche, industry-focused meetings, providing unrivaled knowledge-sharing and networking opportunities to help deliver safe and effective RNA and mRNA therapeutics and vaccines to patients faster.
View the World RNA Series conference calendar below. If you have any questions, get in touch at info@hansonwade.com.
mRNA PORTFOLIO
Advance Your mRNA Pipelines to Front-Line Treatments by Successfully Translating Proof-of-Concepts with Safety, Efficacy & Regulatory Approval
23-25 January, 2024 | Berlin, Germany
Ensuring Critical Regulatory Alignment for Analytical Characterization, Adopting Next-Generation Analytical Methods & Improving mRNA Characterization, Quality & Potency to Safeguard the Commercial Release of Your mRNA Therapeutics & Vaccines
February 13-15, 2024 | Boston, MA
Streamlining Purification, Yield & Scalability of Plasmid & Enzymatic DNA to Harmonize with Regulatory Expectations & Meet Increasing Global Demand for High Quality Therapeutics & Effective Vaccines
March 5-7, 2024 | Boston, MA
Enhance Speed, Purity, Flexibility & Scalability of Your Process Development & Manufacturing to Improve Functionality, Efficacy & Approval Rate of mRNA Drugs Across All Disease Indications
Returning April 2024 | Frankfurt, Germany
Supporting Optimized Purity, Stability & Raw Material Testing for Vaccine Developers to Set Quality Standards at Scale & Avoid GMP Obstacles to Accelerate the Development & Release of Safe & Effective mRNA Medicines
Returning June 2024 | Boston, MA
Fast-Tracking mRNA Therapeutics & Vaccines from Discovery to Commercialization Through Targeted Delivery, Safety & Tolerability to Achieve Clinical Success & Regulatory Harmonization Across All Disease Indications
Returning July 2024 | Boston, MA
Confidently Improve mRNA Characterisation, Quality & Potency with Novel Analytical Tools for Efficient Approval & Commercial Release of Your mRNA Therapeutics & Vaccines
Returning August 2024 | Berlin, Germany
Accelerating mRNA Process Development & Manufacturing from Research to Commercial Scale with Increased Efficiency, Stability & Therapeutic Applicability for Regulatory & Market Readiness
Returning September 2024 | Boston, MA
Improve Immunogenicity, Delivery & CMC of mRNA Cancer Vaccines Towards Accelerated Discovery, Translation & Clinical Development of Next Generation Cancer Treatments for Patients
Returning October 2024 | Boston, MA
Developing Sensitive & Robust Bioanalytical, Analytical & Potency Assays to Accurately Measure Quality, Expression & Efficacy for
Accelerated mRNA Drug Development
December 6-7, 2023 | Boston, MA
RNA PORTFOLIO
Exposing the Latest Chemical & Pharmaceutical Advancements in RNAi Drug Discovery & Development Through Unlocking Novel Targets, Advancing Extra-Hepatic Delivery & Optimizing Chemical Modifications to Ensure Specific & Efficient Delivery to Target Tissues Across Organs & Diseases
February 13-15, 2024 | Boston, MA
Stay Ahead of the Curve with Novel RNA Therapeutics that Offer Exceptional Stability & Durability Whilst Addressing Key Delivery, Pharmacology & Scalability Challenges to Successfully Translate Safe & Effective Next Generation RNA Therapeutics into the Clinic
Returning May 2024 | Boston, MA
Optimize RNA Editing Technology to Safely Deliver Novel Payloads, Enhance Potency & Durability to Achieve Clinical Validation in Patients Faster
Returning July 2024 | Boston, MA
Successfully Develop Sensitive, Reproducible, High-Throughput Screening Tools & Assays to Optimize Hit Finding for Accelerated RNA-Targeted Drug Discovery
Returning August 2024 | Boston, MA
Unlock Native & Engineered Exosomes with Improved Targeting, Optimize Analytics & Achieve GMP Manufacturing for Effective Translation into the Clinic & Towards Commercialization
Returning September 2024 | Boston, MA
Improve Rational Design, Specificity & Selectivity of Small Molecules Targeting RNA to Enable Safe & Effective Drugs to Accelerate into the Clinic
December 12-14, 2023 | Boston, MA